Chemoinformaics analysis of 10-Chlorostrictosidine
| Molecular Weight | 565.019 | nRot | 7 |
| Heavy Atom Molecular Weight | 531.755 | nRig | 29 |
| Exact Molecular Weight | 564.187 | nRing | 5 |
| Solubility: LogS | -2.217 | nHRing | 4 |
| Solubility: LogP | 0.95 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 10 |
| nHA | 10 | APOL | 78.6922 |
| nHD | 6 | BPOL | 42.5678 |
| QED | 0.212 |
| Synth | 4.92 |
| Natural Product Likeliness | 1.951 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.209 |
| HIA | 0.776 |
| CACO-2 | -5.68 |
| MDCK | 0.0000169 |
| BBB | 0.635 |
| PPB | 0.722109 |
| VDSS | 0.988 |
| FU | 0.388852 |
| CYP1A2-inh | 0.023 |
| CYP1A2-sub | 0.137 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.28 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.247 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.348 |
| CYP3a4-inh | 0.221 |
| CYP3a4-sub | 0.539 |
| CL | 1.19 |
| T12 | 0.212 |
| hERG | 0.722 |
| Ames | 0.559 |
| ROA | 0.899 |
| SkinSen | 0.032 |
| Carcinogencity | 0.917 |
| EI | 0.005 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.867854 |